Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Free Cash Flow Generation Index
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Free Cash Flow Generation Index of 0.36x as of September 2025. Free cash flow of CN¥72.90 Million represents 0% of operating cash flow (CN¥201.83 Million). Explore capital reinvestment ratio of Jiangsu Kanion Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jiangsu Kanion Pharmaceutical Co Ltd Free Cash Flow Generation Index (2001–2024)
Historical FCF Generation Index trend for Jiangsu Kanion Pharmaceutical Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see Jiangsu Kanion Pharmaceutical Co Ltd cash conversion from operations.
Annual Free Cash Flow Generation for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Year-by-year Free Cash Flow Generation Index for Jiangsu Kanion Pharmaceutical Co Ltd. Check Jiangsu Kanion Pharmaceutical Co Ltd (600557) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.32x | CN¥225.80 Million | CN¥702.49 Million | CN¥476.69 Million | ▼ -58.0% |
| 2023 | 0.76x | CN¥743.52 Million | CN¥972.32 Million | CN¥297.48 Million | ▼ -3.0% |
| 2022 | 0.79x | CN¥784.85 Million | CN¥995.94 Million | CN¥211.09 Million | ▼ -2.8% |
| 2021 | 0.81x | CN¥736.77 Million | CN¥908.30 Million | CN¥171.52 Million | ▲ +11.3% |
| 2020 | 0.73x | CN¥510.78 Million | CN¥701.10 Million | CN¥190.32 Million | ▲ +54.8% |
| 2019 | 0.47x | CN¥435.67 Million | CN¥925.73 Million | CN¥490.06 Million | ▼ -6.6% |
| 2018 | 0.50x | CN¥320.66 Million | CN¥636.39 Million | CN¥315.73 Million | ▲ +58.2% |
| 2017 | 0.32x | CN¥121.99 Million | CN¥382.93 Million | CN¥260.94 Million | ▲ +463.3% |
| 2016 | -0.09x | CN¥-26.22 Million | CN¥299.02 Million | CN¥325.24 Million | ▼ -132.2% |
| 2015 | 0.27x | CN¥140.00 Million | CN¥514.80 Million | CN¥374.80 Million | ▲ +3786.5% |
| 2014 | 0.01x | CN¥2.18 Million | CN¥311.54 Million | CN¥309.36 Million | ▼ -94.4% |
| 2013 | 0.13x | CN¥48.88 Million | CN¥388.11 Million | CN¥339.23 Million | ▲ +164.0% |
| 2012 | -0.20x | CN¥-41.77 Million | CN¥212.11 Million | CN¥253.88 Million | ▲ +91.3% |
| 2011 | -2.25x | CN¥-203.35 Million | CN¥90.19 Million | CN¥293.53 Million | ▼ -216.6% |
| 2010 | -0.71x | CN¥-118.49 Million | CN¥166.40 Million | CN¥284.89 Million | ▼ -46.9% |
| 2008 | -0.48x | CN¥-28.30 Million | CN¥58.39 Million | CN¥86.69 Million | ▼ -232.8% |
| 2007 | 0.37x | CN¥33.85 Million | CN¥92.73 Million | CN¥58.88 Million | ▼ -52.9% |
| 2006 | 0.78x | CN¥84.46 Million | CN¥108.98 Million | CN¥24.52 Million | ▲ +63.6% |
| 2005 | 0.47x | CN¥48.05 Million | CN¥101.44 Million | CN¥53.39 Million | ▲ +110.2% |
| 2004 | -4.66x | CN¥-101.00 Million | CN¥21.68 Million | CN¥122.68 Million | ▲ +27.2% |
| 2003 | -6.40x | CN¥-109.59 Million | CN¥17.13 Million | CN¥126.72 Million | ▲ +7.2% |
| 2002 | -6.90x | CN¥-76.92 Million | CN¥11.15 Million | CN¥88.07 Million | ▼ -5700.2% |
| 2001 | 0.12x | CN¥2.59 Million | CN¥21.02 Million | CN¥18.43 Million | — |